Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Internal Medicine · HORSEHEADS, NY · NPI 1801050448
Verified facts
CMS Open Payments records show Subodh Kumar Debnath, M.D. received $29.08 in general payments during 2025 across 1 reported records.
Exact Sciences Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $29.08 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $29.08 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $29.08 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 602 | 183 |
| Amlodipine Besylate | Amlodipine Besylate | 446 | 148 |
| Levothyroxine Sodium | Levothyroxine Sodium | 331 | 96 |
| Lisinopril | Lisinopril | 291 | 95 |
| Omeprazole | Omeprazole | 274 | 89 |
| Metoprolol Succinate | Metoprolol Succinate | 235 | 71 |
| Losartan Potassium | Losartan Potassium | 229 | 73 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 226 | 81 |
| Simvastatin | Simvastatin | 200 | 57 |
| Metformin Hcl | Metformin Hcl | 190 | 62 |
| Jardiance | Empagliflozin | 175 | 45 |
| Gabapentin | Gabapentin | 163 | 49 |
| Valsartan | Valsartan | 160 | 52 |
| Hydrochlorothiazide | Hydrochlorothiazide | 152 | 49 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 151 | 49 |
| Pantoprazole Sodium | Pantoprazole Sodium | 142 | 50 |
| Hydralazine Hcl | Hydralazine Hcl | 138 | 42 |
| Fluticasone Propionate | Fluticasone Propionate | 135 | 63 |
| Furosemide | Furosemide | 134 | 49 |
| Metformin Hcl Er | Metformin Hcl | 125 | 34 |
| Montelukast Sodium | Montelukast Sodium | 121 | 38 |
| Tamsulosin Hcl | Tamsulosin Hcl | 107 | 33 |
| Famotidine | Famotidine | 101 | 44 |
| Januvia | Sitagliptin Phosphate | 101 | 25 |
| Sertraline Hcl | Sertraline Hcl | 99 | 41 |
| Alendronate Sodium | Alendronate Sodium | 84 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 82 | 16 |
| Lorazepam | Lorazepam | 80 | 15 |
| Trazodone Hcl | Trazodone Hcl | 77 | 23 |
| Allopurinol | Allopurinol | 70 | 22 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 69 | 54 |
| Farxiga | Dapagliflozin Propanediol | 69 | 17 |
| Metoprolol Tartrate | Metoprolol Tartrate | 69 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 69 | suppressed |
| Carvedilol | Carvedilol | 68 | 25 |
| Diclofenac Sodium | Diclofenac Sodium | 68 | 19 |
| Tradjenta | Linagliptin | 67 | 18 |
| Clopidogrel | Clopidogrel Bisulfate | 65 | 20 |
| Eliquis | Apixaban | 61 | 19 |
| Nifedipine Er | Nifedipine | 59 | 23 |
| Glimepiride | Glimepiride | 58 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 55 | 20 |
| Finasteride | Finasteride | 55 | 18 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 52 | 36 |
| Ezetimibe | Ezetimibe | 51 | 15 |
| Pioglitazone Hcl | Pioglitazone Hcl | 48 | 12 |
| Alprazolam | Alprazolam | 46 | 12 |
| Synthroid | Levothyroxine Sodium | 44 | 15 |
| Atenolol | Atenolol | 43 | 14 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 43 | 34 |
| Pravastatin Sodium | Pravastatin Sodium | 43 | 14 |
| Xarelto | Rivaroxaban | 43 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 42 | suppressed |
| Potassium Chloride | Potassium Chloride | 41 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 40 | 14 |
| Glipizide Er | Glipizide | 39 | 12 |
| Fenofibrate | Fenofibrate Nanocrystallized | 38 | suppressed |
| Azithromycin | Azithromycin | 35 | 27 |
| Irbesartan | Irbesartan | 35 | suppressed |
| Glipizide | Glipizide | 34 | suppressed |
| Temazepam | Temazepam | 33 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 31 | 11 |
| Lovastatin | Lovastatin | 31 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 31 | suppressed |
| Ozempic | Semaglutide | 31 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 30 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | suppressed |
| Sucralfate | Sucralfate | 29 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 28 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 28 | 18 |
| Doxepin Hcl | Doxepin Hcl | 28 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 27 | 23 |
| Methylprednisolone | Methylprednisolone | 27 | 26 |
| Ventolin Hfa | Albuterol Sulfate | 27 | 15 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 26 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 26 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 25 | suppressed |
| Mirtazapine | Mirtazapine | 25 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 25 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 24 | suppressed |
| Hydrocortisone | Hydrocortisone | 24 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 23 | suppressed |
| Fenofibrate | Fenofibrate | 23 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 23 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 23 | suppressed |
| Ssd | Silver Sulfadiazine | 23 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 23 | suppressed |
| Clonazepam | Clonazepam | 22 | suppressed |
| Colchicine | Colchicine | 22 | suppressed |
| Meloxicam | Meloxicam | 22 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 22 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 21 | 11 |
| Mounjaro | Tirzepatide | 21 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Memantine Hcl | Memantine Hcl | 20 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Gemfibrozil | Gemfibrozil | 19 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 18 | 17 |
| Donepezil Hcl | Donepezil Hcl | 18 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 18 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 18 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 17 | 14 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Rybelsus | Semaglutide | 16 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 14 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 13 | 12 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Prednisone | Prednisone | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $29.08 · 1 records | Exact Sciences Corporation | The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error